Cargando…
Mitochondria-Targeted Antioxidants as Potential Therapy for the Treatment of Traumatic Brain Injury
The aim of this article is to review the publications describing the use of mitochondria-targeted antioxidant therapy after traumatic brain injury (TBI). Recent works demonstrated that mitochondria-targeted antioxidants are very effective in reducing the negative effects associated with the developm...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6562849/ https://www.ncbi.nlm.nih.gov/pubmed/31071926 http://dx.doi.org/10.3390/antiox8050124 |
_version_ | 1783426417008050176 |
---|---|
author | Stelmashook, Elena V. Isaev, Nickolay K. Genrikhs, Elisaveta E. Novikova, Svetlana V. |
author_facet | Stelmashook, Elena V. Isaev, Nickolay K. Genrikhs, Elisaveta E. Novikova, Svetlana V. |
author_sort | Stelmashook, Elena V. |
collection | PubMed |
description | The aim of this article is to review the publications describing the use of mitochondria-targeted antioxidant therapy after traumatic brain injury (TBI). Recent works demonstrated that mitochondria-targeted antioxidants are very effective in reducing the negative effects associated with the development of secondary damage caused by TBI. Using various animal models of TBI, mitochondria-targeted antioxidants were shown to prevent cardiolipin oxidation in the brain and neuronal death, as well as to markedly reduce behavioral deficits and cortical lesion volume, brain water content, and DNA damage. In the future, not only a more detailed study of the mechanisms of action of various types of such antioxidants needs to be conducted, but also their therapeutic values and toxicological properties are to be determined. Moreover, the optimal therapeutic effect needs to be achieved in the shortest time possible from the onset of damage to the nervous tissue, since secondary brain damage in humans can develop for a long time, days and even months, depending on the severity of the damage. |
format | Online Article Text |
id | pubmed-6562849 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-65628492019-06-17 Mitochondria-Targeted Antioxidants as Potential Therapy for the Treatment of Traumatic Brain Injury Stelmashook, Elena V. Isaev, Nickolay K. Genrikhs, Elisaveta E. Novikova, Svetlana V. Antioxidants (Basel) Perspective The aim of this article is to review the publications describing the use of mitochondria-targeted antioxidant therapy after traumatic brain injury (TBI). Recent works demonstrated that mitochondria-targeted antioxidants are very effective in reducing the negative effects associated with the development of secondary damage caused by TBI. Using various animal models of TBI, mitochondria-targeted antioxidants were shown to prevent cardiolipin oxidation in the brain and neuronal death, as well as to markedly reduce behavioral deficits and cortical lesion volume, brain water content, and DNA damage. In the future, not only a more detailed study of the mechanisms of action of various types of such antioxidants needs to be conducted, but also their therapeutic values and toxicological properties are to be determined. Moreover, the optimal therapeutic effect needs to be achieved in the shortest time possible from the onset of damage to the nervous tissue, since secondary brain damage in humans can develop for a long time, days and even months, depending on the severity of the damage. MDPI 2019-05-08 /pmc/articles/PMC6562849/ /pubmed/31071926 http://dx.doi.org/10.3390/antiox8050124 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Perspective Stelmashook, Elena V. Isaev, Nickolay K. Genrikhs, Elisaveta E. Novikova, Svetlana V. Mitochondria-Targeted Antioxidants as Potential Therapy for the Treatment of Traumatic Brain Injury |
title | Mitochondria-Targeted Antioxidants as Potential Therapy for the Treatment of Traumatic Brain Injury |
title_full | Mitochondria-Targeted Antioxidants as Potential Therapy for the Treatment of Traumatic Brain Injury |
title_fullStr | Mitochondria-Targeted Antioxidants as Potential Therapy for the Treatment of Traumatic Brain Injury |
title_full_unstemmed | Mitochondria-Targeted Antioxidants as Potential Therapy for the Treatment of Traumatic Brain Injury |
title_short | Mitochondria-Targeted Antioxidants as Potential Therapy for the Treatment of Traumatic Brain Injury |
title_sort | mitochondria-targeted antioxidants as potential therapy for the treatment of traumatic brain injury |
topic | Perspective |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6562849/ https://www.ncbi.nlm.nih.gov/pubmed/31071926 http://dx.doi.org/10.3390/antiox8050124 |
work_keys_str_mv | AT stelmashookelenav mitochondriatargetedantioxidantsaspotentialtherapyforthetreatmentoftraumaticbraininjury AT isaevnickolayk mitochondriatargetedantioxidantsaspotentialtherapyforthetreatmentoftraumaticbraininjury AT genrikhselisavetae mitochondriatargetedantioxidantsaspotentialtherapyforthetreatmentoftraumaticbraininjury AT novikovasvetlanav mitochondriatargetedantioxidantsaspotentialtherapyforthetreatmentoftraumaticbraininjury |